2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物
| 中文名称 | 2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物 |
|---|---|
| 中文同义词 | 2 - (4 -羧基苯基)-4,4,5,5 -四甲基咪唑啉-3 -氧化钾盐;2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物;2-(4-羧基苯基)-4,4,5,5-四甲基咪唑啉-1-氧-3-氧化钾盐;羧基-PTIO 钾盐;化合物 T22623;PERFEMIKER]羧基-PTIO 钾盐,98%;化合物 CARBOXY-PTIO POTASSIUM;CARBOXY-PTIO,POTASSIUM SALT |CAS 148819-94-7 |
| 英文名称 | CARBOXY-PTIO |
| 英文同义词 | CARBOXY-PTIO;CARBOXY-PTIO POTASSIUM;CARBOXY-PTIO, POTASSIUM SALT;2-(4-CARBOXYPHENYL)-4,4,5,5-TETRAMETHYL-IMIDAZOLINE-1-OXYL-3-OXIDE POTASSIUM;2-(4-CARBOXYPHENYL)-4,4,5,5-TETRAMETHYLIMIDAZOLINE-1-OXYL-3-OXIDE, POTASSIUM SALT;2-(4-CARBOXYPHENYL)-4,5-DIHYDRO-4,4,5,5-TETRAMETHYL-1H-IMIDAZOL-1-YLOXY-3-OXIDE POTASSIUM;2-(4-CARBOXYPHENYL)-4,5-DIHYDRO-4,4,5,5-TETRAMETHYL-1H-IMIDAZOLYL-1-OXY-3-OXIDE, POTASSIUM SALT;2-(4-CARBOXYPHENYL)-4,5-DIHYDRO-4,4,5,5-TETRAMETHYLIMIDAZOLINE-3-OXIDE-1-OXYL, POTASSIUM SALT |
| CAS号 | 148819-94-7 |
| 分子式 | C14H16KN2O4* |
| 分子量 | 315.39 |
| EINECS号 | |
| 相关类别 | Nitric Oxide Reagents |
| Mol文件 | 148819-94-7.mol |
| 结构式 |  |
2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物 性质
| 熔点 | 141-143°C |
|---|---|
| 储存条件 | 2-8°C |
| 溶解度 | H2O: >20 mg/mL |
| 形态 | 固体 |
| 颜色 | 蓝色的 |
| 生物来源 | synthetic (organic) |
| 水溶解性 | Soluble in water. Also soluble in ethanol, methanol, DMSO or DMF. |
| 稳定性 | 供货时可稳定保存 2 年。 DMSO 或蒸馏水中的溶液可在 -20°C 下保存长达 1 个月。 |
| InChI | 1S/C14H17N2O4.K/c1-13(2)14(3,4)16(20)11(15(13)19)9-5-7-10(8-6-9)12(17)18;/h5-8H,1-4H3,(H,17,18);/q;+1/p-1 |
| InChIKey | VYEUQMVIGXFZQU-UHFFFAOYSA-M |
| SMILES | [K+].CC1(C)N([O])C(c2ccc(cc2)C([O-])=O)=[N+]([O-])C1(C)C |
| CAS 数据库 | 148819-94-7(CAS DataBase Reference) |
Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) significantly suppresses the stimulation of NO expression induced by physalin A treatment, but no change is observed in Carboxy-PTIO treatment alone.Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) reduces physalin A-induced cleavage of procaspase-3 and PARP, down-regulated ICAD expression,diminishing DNA fragmentation in nuclei.Carboxy-PTIO potassium (200 μM; 1 h prior to physalin A; 24 hours) shows no effect on iNOS expression. However, decreased-mTOR and p-mTOR levels induced by physalin A is reversed by Carboxy-PTIO with concomitant suppression of LC3 I to LC3 II conversions in A375-S2 cells .
Western Blot Analysis
| Cell Line: | A375-S2 cells |
| Concentration: | 200 μM |
| Incubation Time: | 1 h prior to physalin A; 24 hours |
| Result: | Diminished physalin A-induced procaspase-3 and PARP cleavage. |
Carboxy-PTIO (intravenous injection; 0.056-1.70 mg/kg/min; infused for 1 hr beginning 90 min after the LPS injection 90 min) treatment improves the hypotension, renal dysfunction and survival rate in Lps-treated rats. But it does not affect each parameter in naomal rats.
| Animal Model: | SD rats |
| Dosage: | 0.056-1.70 mg/kg/min |
| Administration: | Intravenous injection; 0.056-1.70 mg/kg/min; infused for 1 hr beginning 90 min after the LPS injection 90 min |
| Result: | Exhibited a potent therapeutic value in endotoxin shock through the direct scavenging action against NO. |
安全信息
| 安全说明 | 24/25 |
|---|---|
| WGK Germany | 3 |
| 海关编码 | 2918999090 |
| 存储类别 | 11 - 可燃固体 |
| 提供商 | 语言 |
|---|---|
|
英文
|
|
|
英文
|
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-18734A | 2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物 Carboxy-PTIO potassium | 148819-94-7 | 5 mg | 800元 |
| 2026/06/05 | HY-18734A | 2-4-羧苯基四甲基咪唑烷-1-氧-3-氧化物 Carboxy-PTIO potassium | 148819-94-7 | 10 mM * 1 mL in Water | 880元 |